The need for effective therapy to treat Alzheimer’s disease is greater than ever, but there is still no drug therapy that can stop or reverse the progression of the disease. There is, however, a great deal of anticipation for the imminent development of effective therapies as a result of the identification of promising targets for drug development. This book investigates these targets and examines ongoing strategies to develop effective therapies for this devastating neurodegenerative condition. The authors, leading pioneers in the development of current and experimental therapies, discuss a wide range of pharmacological mechanisms underlying these new therapies. The book is of interest to researchers, scientists, clinicians, and graduate students in the pharmaceutical sciences and pharmacology, neuroscience, immunology, and medicine.